Stockpicker Comparison Tool

Stock A

GSK ×

Stock B

CI ×

Stock C

Stock D

Revenue Growth GSK 5.30% ▲ 3.79% CI 6.60% ▲ 2.03% Gross Margin GSK 73.05% ▼ -2.37% CI 20.88% ▲ 11.43% Free Cash Flow GSK $2.96B ▲ $2.02B CI -$718.00M ▼ -$1.58B Net Debt / EBITDA GSK 1.38 ▼ -0.44 CI 2.17 ▲ 0.28 Operating Margin GSK 5.72% ▼ -24.34% CI 3.73% ▲ 0.29% P/E Ratio GSK 16.82 ▲ 3.67 CI 11.83 ▼ -0.30

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.